CanadaBis Capital Inc. and 1926360 Alberta Ltd. (dba Stigma Pharmaceuticals) Receive TSXV Conditional Acceptance
Standard Uranium Provides Update on $3 Million Strategic Investment and Announces Extension to Closing Date of Private Placement